Selexipag Delays PAH Progression in Patients with Connective Tissue DiseaseResults of a subgroup analysis from the GRIPHON trial are promising for a hard-to-treat population.
New Biomarker Could Improve ARDS, AHF DiagnosisA biomarker of myocardial strain and inflammation may be able to discriminate between two similar pulmonary emergencies.
Methamphetamine-associated PAH: First Prospective Cohort StudyMethamphetamine abuse is on a steady rise in the US. A new study highlights the nature and dangers of Meth-PAH.
Hypertension, Target Organ Injury, and the BrainQuiz: Are you current on early evidence that suggests hypertension is a risk factor for Alzheimer disease and other dementias? .
Dose-adjusted DOACs vs Warfarin: Overview of EfficacyPatients who require dose adjustment when taking direct oral anticoagulants have not been well studied. This large study is a good start.
No Difference in CV Outcomes with Statin plus Add-on vs Statin AloneThe HIJ-PROPER study found intensive LDL-lowering therapy added no additional therapeutic value in patients with ACS.
Hellenic Heart Failure Study: Impact of Mediterranean Diet on Recurrent ACSResults of this study suggest a role for the anti-inflammatory diet in secondary prevention.
Aspirin, Clopidogrel, DOAC, Warfarin: What Combination after PCI in Patients with AF?Quick Quiz: Which antiplatelet/antithrombin combination provides greatest efficacy with least risk for bleeding?
Toward Improved Risk Stratification in Pulmonary Arterial HypertensionA new study supports the utility of pulmonary arterial proportional pulse pressure to predict 5-year mortality in patients with PAH.
Traditional Cardiovascular Risk Factors and Systemic Lupus Erythematosus: A Bad CombinationCaution: Approach every patient with SLE as a “bundle of cardiovascular risks” greater than the sum of its parts